Gland Pharma Limited engages in the development, manufacture, and marketing of injectable-focused generic liquid parenteral products. The company's primary molecules include heparin sodium, enoxaparin sodium, rocuronium bromide, and daptomycin injections, as well as others. It offers its products under various therapeutic categories, such as anti-infectives, anesthetics, anti-coagulants and their antidotes, anti-malarial, cardiology, gastro-intestinal, pain management, hormones and related drugs, fertility supplements, Gnrh agonists and antagonists, anti-neoplastic, gynecological, neurological and central nervous system, respiratory, blood related, ophthalmological and otological, pain/analgesics, orthopedics, hematinic, vitamins/minerals/nutrients, and others. The company also provides contract development services. It sells its products primarily under a business to business in the United States, Europe, Canada, Australia, India, and internationally. The company was incorporated in 1978 and is based in Hyderabad, India. Gland Pharma Limited is a subsidiary of Fosun Pharma Industrial Pte. Ltd.

Dr. Surapanini  Sridevi

Senior Vice President of R&D

Ms. Shilpi  Sahay

Deputy General Manager of Human Resources

Mr. Ankit  Gupta

Vice President of Strategy & Investments

Mr. Surinder  Koul

Head of Domestic Marketing

Mr. Sampath Kumar Pallerlamudi

Company Secretary & Compliance Officer

Mr. Srinivas  Sadu

MD, Chief Executive Officer & Executive Director

Mr. Ravi Shekhar Mitra

Chief Financial Officer

Mr. Prakash Vithal Baliga

Chief Operating Officer

Mr. Sumanta  Bajpayee

Vice President of Investor Relations

Dr. C. S. Venkatesan

Gland Pharma Limited

Gland Pharma Limited Структура на управлението

Информация за управлението